The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium

Saudi Medical Journal

Volumn 28, Issue 12, 2007, Pages 1836-1839

  Kayali, Cemil ^a,b   Agus, Haluk ^a   Surer, Levent ^a   Turgut, Ali ^a  

^a Tepecik Education and Researh Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; PARACETAMOL; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANKLE SPRAIN; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL ADMISSION; HUMAN; KNEE INJURY; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PARALLEL DESIGN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; TURKEY (REPUBLIC); VISUAL ANALOG SCALE; ANKLE INJURY; COMPARATIVE STUDY; INJURY; PAIN; TREATMENT OUTCOME;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; ANKLE INJURIES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PAIN; SPRAINS AND STRAINS; TREATMENT OUTCOME;

EID: 41149157614     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Yeung MS, Chan KM, So CH, Yuan WY. An epidemiological survey on ankle sprain. Br J Sport Med 1994; 28: 112-116.
2. Otter SJ. The conservative management of lateral ankle sprains in the athlete. Foot 1999; 9: 12-17.
3. Puffer JC. The sprained ankle. Clin Cornerstone 2001; 3: 38-49.
4. Pellow JE, Brantingham JW. The Efficacy of adjusting the ankle in the treatment of subacute and chronic grade I and grade II ankle inversion sprains. J Manipulative Physiol Ther 2001; 24: 17-24.
5. Birrer RB, Fani-Salek MH, Totten VY, Herman LM, Politi V. Managing ankle injuries in the emergency department. J Emerg Med 1999; 17: 651-660.
6. Dubois RW, Melmed GY, Henning JM, Bernal M. Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the Literature. J Clin Rheum 2004; 10: 178-189.
7. Petrella R, Ekman E, Schuller R, Fort JG. Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: Results of a double-blind, randomized controlled trial. Clin J Sports Med 2004; 14: 225-231.
8. Colville MR, Amendola N, Butters MA, editors. Clinical guideline on ankle injury. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1997.
9. Wolfe MW, Uhl TL, Mattacola CG McCluskey LC. Management of ankle sprains. Am Fam Physician 2001; 63: 93-104.
10. Payan DG, Shearn MA. Nonsteroidal anti-inflammatory drugs; nonopioid analgesics; drugs used in Gout. In: Katzung BG, editor. Basic and Clinical Pharmacology. Appleton-Lange, East Norwalk (CT); 1989. p. 444.
11. Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf 2005; 28: 227-240.
12. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wilholm BE. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: A meta-analysis based on individual patient data. Br J Clin Pharmacol 2002; 54: 320-326.
13. Dalton J, Schweinle JE. Efficacy and safety of extended release acetaminophen vs ibuprofen for treatment of ankle sprains. American College of Sports Medicine 2005; 37: 355.
14. Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: Results rom the ASSET trial. Headache 2005; 45: 973-982.
15. Naesh O, Niles LA, Gilbert JG, Ammar MM, Phibbs PW, Phillips AM, et al. A randomized, placebo-controlled study of rofecoxib with paracetamol in early post-tonsillectomy pain in adults. Eur J Anaesthesiol 2005; 22: 768-773.
16. Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician 2005; 71: 913-918.
17. Spiler NM, Rork TH, Merrill GF. An old drug with a new purpose: cardiovascular actions of acetaminophen (paracetamol). Curr Drug Targets-Cardiovasc Haematol Disord 2005; 5: 419-429.
18. Wu SS, Tuan K. Current concepts in nonoperative management of knee osteoarthritis. Orthopedics 2005; 28: 134-139.
19. Kean WF, Buchanan WW. The use of NSAIDs in rheumatic disorders 2005: A global perspective. Inflammopharmacology 2005: 13: 343-370.
20. Duncan JJ, Farr JE. Comparison of diclofenac sodium and aspirin in the treatment of acute sports injuries. Am J Sports Med 1988; 16: 656-659.
21. McIlwain HH, Platt RD. Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes. Am J Med 1988; 84: 56-60.
22. Tachibana M, Inoue N, Yoshida E, Matsui M, Ukai Y, Yano J. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Pharmacology 2003; 68: 96-104.
23. Bender T, Schafer M, Bariska J. Tissue concentration of the active substance of Voltaren SR75 in articular cartilage, synovial membrane and bone. Clin Rheumatol 2000; 19: 89-91.
24. Lung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, et al. A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: A herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. Am J Chin Med 2004; 32: 291-301.